Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

Erez N. Baruch, Ilan Youngster, Guy Ben‐Betzalel, +28

Science

Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence

Michal Harel, Rona Ortenberg, Siva Karthik Varanasi, +23

Cell

MedicineMelanomaImmunologyTranslational ProteomicsProteomics +3

The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model

Michael Blank, Liat Anafi, Gisele Zandman‐Goddard, +8

International Immunology

A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme

Gilli Galore-Haskel, Yael Nemlich, Eyal Greenberg, +11

Oncotarget

ADAR1-mediated regulation of melanoma invasion

Yael Nemlich, Erez N. Baruch, Michal J. Besser, +7

Nature Communications

Transcriptional RegulationSkin CancerDifferent Migratory StrategiesMedicineMelanoma Invasion +12

Interleukin-1α deficiency attenuates endoplasmic reticulum stress-induced liver damage and CHOP expression in mice

Michal Kandel-Kfir, Tal Almog, Aviv Shaish, +7

Journal of Hepatology

InflammationCytokineMedicineLiver PhysiologyImmunology +11

Abstract CT042: Fecal microbiota transplantation (FMT) and re-induction of anti-PD-1 therapy in refractory metastatic melanoma patients - preliminary results from a phase I clinical trial (NCT03353402)

Erez N. Baruch, Ilan Youngster, Rona Ortenberg, +22

Cancer Research

Ideal EngraftmentAnti-pd-1 TherapyMedicineMelanomaImmunology +11

Blastemal NCAM+ALDH1+ Wilms' tumor cancer stem cells correlate with disease progression and poor clinical outcome: A pilot study

Dani Raved, Itay Tokatly-Latzer, Liat Anafi, +4

Pathology - Research and Practice

Hematological MalignancyTumor BiologyOncologyDisease ProgressionMedicine +9

TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients

Maya Dadiani, Daniela Necula, Smadar Kahana‐Edwin, +14

Cancer Immunology Immunotherapy

Breast OncologyOncologyImproved SurvivalMedicinePathology +6

MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

Ettai Markovits, Ortal Harush, Erez N. Baruch, +15

Cancer Immunology Research